Anticancer activities of essential oils constituents and synergy with conventional therapies: A review

Phytotherapy Research

Volumn 28, Issue 10, 2014, Pages 1423-1446

  Lesgards, Jean François ^a   Baldovini, Nicolas ^b   Vidal, Nicolas ^a   Pietri, Sylvia ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

apoptosis; essential oils; membrane potential; oxidative stress; terpenoids

Indexed keywords

AROMATIC COMPOUND; BETA CAROPHYLLENE; BETA ELEMENE; BISABOLOL; CARVACROL; CASPASE 3; CASPASE 9; CISPLATIN; DOCETAXEL; DOXORUBICIN; ESSENTIAL OIL; EUGENOL; FARNESOL; FLUOROURACIL; GEMCITABINE; GERANIOL; GERMACRONE; HUMULENE; LIMONENE; NEROLIDOL; PACLITAXEL; PERILLYL ALCOHOL; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; SIMVASTATIN; SULFORAPHANE; TERPENOID; THYMOL; THYMOQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTINEOPLASTIC AGENT; CASPASE; VEGETABLE OIL;

ADENOCARCINOMA; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER INHIBITION; CANCER MODEL; CANCER RADIOTHERAPY; CELL CYCLE REGULATION; COLON TUMOR; COLORECTAL CANCER; DIARRHEA; DNA STRAND BREAKAGE; DRUG ABSORPTION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TOLERANCE; ENZYME ACTIVATION; ENZYME INACTIVATION; FATIGUE; FIBROSARCOMA; GASTROINTESTINAL IRRITATION; GASTROINTESTINAL SYMPTOM; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOKALEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LD 50; LEUKEMIA; LIVER CANCER; LUNG CANCER; MELANOMA; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIPLE CYCLE TREATMENT; MUTAGEN TESTING; NAUSEA; NAUSEA AND VOMITING; NEUROBLASTOMA; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; OXIDATIVE STRESS; PANCREAS CANCER; PANCREAS TUMOR; PHASE 1 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SKIN TUMOR; SOLID TUMOR; STOMACH CANCER; STOMACH CARCINOMA; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME; ANIMAL; CELL DEATH; DRUG EFFECTS; MEMBRANE POTENTIAL; METABOLISM; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL DEATH; CELL LINE, TUMOR; DRUG SYNERGISM; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMBRANE POTENTIALS; NEOPLASMS; OILS, VOLATILE; PLANT OILS;

EID: 84908508576     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5165     Document Type: Review

References (184)

1. Abukhader MM,. 2012. The effect of route of administration in thymoquinone toxicity in male and female rats. Indian J Pharm Sci 74 (3): 195 - 200.
2. Afoulous S, Ferhout H, Raoelison EG, et al. 2011. Helichrysum gymnocephalum essential oil: chemical composition and cytotoxic, antimalarial and antioxidant activities, attribution of the activity origin by correlations. Molecules 16: 8273 - 8291.
3. Ahmad ST, Arjumand W, Seth A, et al. 2011. Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways. Toxicology 290 (1): 69 - 81.
4. Ait Mbarek L, Ait Mouse H, Elabbadi N, et al. 2007. Anti-tumor properties of blackseed (Nigella sativa L.) extracts. Braz J Med Biol Res 40 (6): 839 - 47.
5. Al-Ali A, Alkhawajah Abdul A, Randhawa Mohammad A, Shaikh Nisar A,. 2008. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med College 20 (2): 25 - 7.
6. Amiel E, Ofir R, Dudai N, Soloway E, Rabinsky T, Rachmilevitch S,. 2012. β -Caryophyllene, a compound isolated from the biblical balm of gilead (Commiphora gileadensis), is a selective apoptosis inducer for tumor cell lines. Evid base Compl Alternative Med: eCAM 2012: 872394.
7. Ariyoshi T, Arakaki M, Ideguchi K, Ishizuka Y, Noda K,. 1975. Studies on the metabolism of d-Limonene (p-Mentha-1,8-diene). III. Effects of d-Limonene on the lipids and drug-metabolizing enzymes in rat livers. Xenobiotica 5 (1): 33 - 8.
8. Asamoto M, Ota T, Toriyama-Baba H, Hokaiwado N, Naito A, Tsuda H,. 2002. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Jpn J Cancer Res 93 (1): 32 - 35.
9. Attoub S, Sperandio O, Raza H, et al. 2013. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fund Clin Pharmacol 27 (5): 557 - 69.
10. Austgulen LT, Solheim E, Scheline RR,. 1987. Metabolism in rats of p-cymene derivatives: carvacrol and thymol. Pharmacol Toxicol 61 (2): 98 - 102.
11. Austin CA, Shephard EA, Pike SF, Rabin BR, Phillips IR,. 1988. The effect of terpenoid compounds on cytochrome P-450 levels in rat liver. Biochem Pharmacol 37 (11): 2223 - 9.
12. Azizan A, Blevins RD,. 1995. Mutagenicity and antimutagenicity testing of six chemicals associated with the pungent properties of specific spices as revealed by the Ames Salmonella/microsomal assay. Arch Environ Contam Toxicol 28 (2): 248 - 58.
13. Badary OA, Al-Shabanah OA, Nagi MN, Al-Bekairi AM, Elmazar MMA,. 1998. Acute and subchronic toxicity of thymoquinone in mice. Drug Dev Res 44 (2/3): 54 - 61.
14. Bakkali F, Averbeck S, Averbeck D, Idaomar M,. 2008. Biological effects of essential oils-a review. Food Chem Toxicol 46: 446 - 475.
15. Balaji S, Chempakam B,. 2010. Toxicity prediction of compounds from turmeric (Curcuma longa L). Food Chem Toxicol 48 (10): 2951 - 2959.
16. Bao F, Qiu J, Zhang H,. 2012. Potential role of β -elemene on histone H1 in the H22 ascites hepatoma cell line. Mol Med Rep 6 (1): 185 - 190.
17. Belanger JT,. 1998. Perillyl alcohol: applications in oncology. Alternative Med Rev J Clin Therapeut 3 (6): 448 - 57.
18. Bhatia SP, McGinty D, Letizia CS, Api AM,. 2008. Fragrance material review on α-bisabolol. Food Chem Toxicol 46 (11S): S72 - S76.
19. Brown M, Cohen J, Arun P, Chen Z, Van Waes C,. 2008. NF-κ B in carcinoma therapy and prevention. Expert Opin Ther Targets 12 (9): 1109 - 1122.
20. Burdock GA, Wagner BM, Smith RL, Munro IC, Newberne PM,. 1990. Recent progress in the consideration of flavoring ingredients under the food additives amendment. 15. GRAS substances. Food Technol 44 (2): 78 - 86.
21. Burke YD, Stark MJ, Roach SL, Sen SE, Crowell PL,. 1997. Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32 (2): 151 - 156.
22. Buzzai M, Bauer DE, Jones RG, et al. 2005. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β -oxidation. Oncogene 24 (26): 4165 - 4173.
23. Cano CE, Gommeaux J, Pietri S, et al. 2009. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 69: 219 - 226.
24. Cardozo Monica T, de Conti A, Ong Thomas P, et al. 2011. Chemopreventive effects of β -ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J Nutr Biochem 22 (2): 130 - 5.
25. Cardozo MT, de Conti A, Ong TP, et al. 2011. Chemopreventive effects of β -ionone and geraniol during rat hepatocarcinogenesis promotion: distinct actions on cell proliferation, apoptosis, HMGCoA reductase, and RhoA. J Nutr Biochem 22 (2): 130 - 135.
26. Carnesecchi S, Bras-Goncalves R, Bradaia A, et al. 2004. Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. Canc lett 215 (1): 53 - 9.
27. Carnesecchi S, Schneider Y, Ceraline J, et al. 2001. Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. J Pharmacol Exp Therapeut 298 (1): 197 - 200.
28. Carnesecchi S, Bradaia A, Fischer B, et al. 2002. Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells. J Pharmacol Exp Therapeut 303 (2): 711 - 715.
29. Caujolle F, Franck C,. 1944. Comparative toxicity of thymol and carvacrol. Bull Soc Chim Biol 26: 334 - 42.
30. Cavalieri E, Mariotto S, Fabrizi C, et al. 2004. α-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem Biophys Res Commun 315 (3): 589 - 594.
31. Cavalieri E, Rigo A, Bonifacio M, et al. 2011. Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells. J Transl Med 9: 45.
32. Cavalieri E, Bergamini C, Mariotto S, et al. 2009. Involvement of mitochondrial permeability transition pore opening in α-bisabolol induced apoptosis. FEBS J 276 (15): 3990 - 4000.
33. Cha J-D, Moon S-E, Kim H-Y, Cha I-H, Lee K-Y,. 2009. Essential oil of Artemisia capillaris induces apoptosis in KB cells via mitochondrial stress and caspase activation mediated by MAPK-stimulated signaling pathway. J Food Sci 74 (9): T75 - T81.
34. Chander SK, Lansdown AGB, Luqmani YA, et al. 1994. Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumors. Br J Cancer 69 (5): 879 - 82.
35. Chang H-T, Hsu S-S, Chou C-T, et al. 2011. Effect of thymol on Ca homeostasis and viability in MG63 human osteosarcoma cells. Pharmacology 88 (3-4): 201 - 212.
36. Chaudhary SC, Siddiqui MS, Athar M, Alam MS,. 2012. D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis. Hum Exp Toxicol 31 (8): 798 - 811.
37. Chaves JS, Leal PC, Pianowisky L, Calixto JB,. 2008. Pharmacokinetics and tissue distribution of the sesquiterpene α-humulene in mice. Planta Med 74: 1678 -1683.
38. Chen W, Hou J, Yin Y, et al. 2010. α-Bisabolol induces dose-and time-dependent apoptosis in HepG2 cells via a Fas-and mitochondrial-related pathway, involves p53 and NFκ B. Biochem Pharmacol 80 (2): 247 - 254.
39. Chen W, Lu Y, Wu J, Gao M, Wang A, Xu B,. 2011a. Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis. Cancer Chemother Pharmacol 67 (4): 799 - 808.
40. Chen X, Pei L, Zhong Z, Guo J, Zhang Q, Wang Y,. 2011b. Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine 18 (14): 1238 - 1243.
41. Clark GC,. 1988. Acute inhalation toxicity of eugenol in rats. Arch Toxicol 62 (5): 381 - 6.
42. Costarelli L, Malavolta M, Giacconi R, et al. 2010. In vivo effect of α-bisabolol, a nontoxic sesquiterpene alcohol, on the induction of spontaneous mammary tumors in HER-2/neu transgenic mice. Oncol Res 18 (9): 409 - 418.
43. Crowell PL,. 1999. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 129 (3): 775S - 778S.
44. Crowell PL, Elson CE, Bailey HH, Elegbede A, Haag JD, Gould MN,. 1994. Human metabolism of the experimental cancer therapeutic agent d-limonene. Cancer Chemother Pharmacol 35 (1): 31 - 7.
45. da Silva AP, Martini MV, de Oliveira CMA, et al. 2010. Antitumor activity of (-)-α-bisabolol-based thiosemicarbazones against human tumor cell lines. Eur J Med Chem 45 (7): 2987 - 2993.
46. Darra E, Abdel-Azeim S, Manara A, et al. 2008. Insight into the apoptosis-inducing action of alpha-bisabolol towards malignant tumor cells: involvement of lipid rafts and Bid. Arch Biochem Biophys 476 (2): 113 - 23.
47. Das S, Dey KK, Dey G, et al. 2012. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One 7 (10): e46641.
48. De Sousa AC, Alviano DS, Blank AF, Alves PB, Alviano CS, Gattass CR,. 2004. Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J Pharm Pharmacol 56 (5): 677 - 681.
49. De Vincenzi M, Stammati A, De Vincenzi A, Silano M,. 2004. Constituents of aromatic plants: carvacrol. Fitoterapia 75 (7-8): 801 - 804.
50. Deb Dipanwita D, Parimala G, Saravana Devi S, Chakraborty T,. 2011. Effect of thymol on peripheral blood mononuclear cell PBMC and acute promyelotic cancer cell line HL-60. Chem Biol Interact 193 (1): 97 - 106.
51. DeBarber AE, Bleyle LA, Roullet J-BO, Koop DR,. 2004. ω-Hydroxylation of farnesol by mammalian cytochromes P 450. Biochim Biophys Acta Mol Cell Biol Lipids 1682 (1-3): 18 - 27.
52. DeBerardinis RJ, Mancuso A, Daikhin E, et al. 2007. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104 (49): 19345 - 19350.
53. DeFeudis FV,. 1998. Ginkgo biloba Extract (EGb 761): From Chemistry to the Clinic. Ullstein Medical: Wiesbaden.
54. Duncan RE, Lau D, El-Sohemy A, Archer MC,. 2004. Geraniol and β -ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem Pharmacol 68 (9): 1739 - 1747.
55. Edris AE,. 2009. Anti-cancer properties of Nigella spp. essential oils and their major constituents, thymoquinone and β -elemene. Curr Clin Pharmacol 4 (1): 43 - 46.
56. Effenberger-Neidnicht K, Schobert R,. 2011. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother Pharmacol 67 (4): 867 - 874.
57. El Babili F, Bouajila J, Souchard JP, et al. 2011. Oregano: clinical analysis and evaluation of its antimalarial, antioxidant, and cytotoxic activities. J Food Sci 76 (3): C512 - C518.
58. Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN,. 1984. Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 5 (5): 661 - 4.
59. Elegbede JA, Maltzman TH, Elson CE, Gould MN,. 1993. Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis 14 (6): 1221 - 3.
60. Elson CE, Yu SG,. 1994. The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J Nutr 124 (5): 607 - 14.
61. Gali-Muhtasib H, Kuester D, Mawrin C, et al. 2008. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. Cancer Res 68 (14): 5609 - 5618.
62. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP,. 2005. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 280 (7): 5812 - 5819.
63. Gilliam Laura AA, St Clair Daret K,. 2011. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxidants redox signaling 15 (9): 2543 - 63.
64. Giraud AMP,. 2002. Essential oil combination and therapeutic uses thereof. WO 2002007744 A1.
65. Gommeaux J, Cano C, Garcia S, et al. 2007. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 27: 2215 - 2228.
66. Goodsell DS,. 1999. The molecular perspective: the ras oncogene. Oncologist 4 (3): 263 - 4.
67. Gould MN,. 1997. Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect Suppl 105 (4): 977 - 979.
68. Gould MN, Moore CJ, Zhang R, Wang B, Kennan WS, Haag JD,. 1994. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res 54 (13): 3540 - 3.
69. Haag JD, Lindstrom MJ, Gould MN,. 1992. Limonene-induced regression of mammary carcinomas. Cancer Res 52 (14): 4021 - 6.
70. Habersang S, Leuschner F, Isaac O, Thiemer K,. 1979. Pharmacological studies of chamomile constituents. IV. Studies on the toxicity of (-)-α-bisabolol. Planta Med 37 (2): 115 - 23.
71. He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE,. 1997. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 127 (5): 668 - 674.
72. Homburger F, Treger A, Boger E,. 1970. Inhibition of murine subcutaneous and intravenous benzo[rst]pentaphene carcinogenesis by sweet orange oils and (+)-limonene. Oncology 25 (1): 1 - 10.
73. Hsu S-S, Lin K-L, Chou C-T, et al. 2011. Effect of thymol on Ca2+ homeostasis and viability in human glioblastoma cells. Eur J Pharmacol 670 (1): 85 - 91.
74. Hudes GR, Szarka CE, Adams A, et al. 2000. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clin Cancer Res 6 (8): 3071 - 3080.
75. Hussain A, Priyani A, Sadrieh L, Brahmbhatt K, Ahmed M, Sharma C,. 2012. Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells. Integr Cancer Ther 11 (2): 154 - 165.
76. Hussain A, Brahmbhatt K, Priyani A, Ahmed M, Rizvi TA, Sharma C,. 2011. Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer Biotherapy Radiopharm 26 (5): 519 - 527.
77. Idaomar M, El Hamss R, Bakkali F, et al. 2002. Genotoxicity and antigenotoxicity of some essential oils evaluated by wing spot test of Drosophila melanogaster. Mutat Res Genet Toxicol Environ Mutagen 513 (1-2): 61 - 68.
78. Ishida T, Toyota M, Asakawa Y,. 1989. Terpenoid biotransformation in mammals. V. Metabolism of (+)-citronellal, (±)-7-hydroxycitronellal, citral, (-)-perillaldehyde, (-)-myrtenal, cuminaldehyde, thujone, and (±)-carvone in rabbits. Xenobiotica fate foreign compd biol syst 19 (8): 843 - 55.
79. Ivankovic S, Stojkovic R, Jukic M, Milos M, Jurin M,. 2006. The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo. Exp Oncol 28 (3): 220 - 224.
80. Jaganathan SK, Mazumdar A, Mondhe D, Mandal M,. 2011. Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35 (6): 607 - 615.
81. Jager W, Mayer M, Reznicek G, Buchbauer G,. 2001. Percutaneous absorption of the monoterpene carvone: implication of stereoselective metabolism on blood levels. J Pharm Pharmacol 53 (5): 637 - 642.
82. Jenner PM, Hagan EC, Taylor JM, Cook EL, Fitzhugh OG,. 1964. Food flavorings and compounds of related structure. I Acute oral toxicity Food Cosmet Toxicol 2 (3): 327 - 43.
83. Ji J, Zhang L, Wu Y-Y, Zhu X-Y, Lv S-Q, Sun X-Z,. 2006. Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. Leuk Lymphoma 47 (12): 2617 - 2624.
84. Jirtle RL, Haag JD, Ariazi EA, Gould MN,. 1993. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β 1 levels during monoterpene-induced regression of mammary tumors. Cancer Res 53 (17): 3849 - 52.
85. Jrah-Harzallah H, Ben-Hadj-Khalifa S, Almawi Wassim Y, Maaloul A, Houas Z, Mahjoub T,. 2013. Effect of thymoquinone on 1,2-dimethyl-hydrazine-induced oxidative stress during initiation and promotion of colon carcinogenesis. Eur J Cancer 49 (5): 1127 - 1135.
86. Kamatou GP, Vermaak I, Viljoen AM,. 2012. Eugenol-from the remote Maluku islands to the international market place: a review of a remarkable and versatile molecule. Molecules 17: 6953 - 6981.
87. Kanerva RL, Alden CL,. 1987. Review of kidney sections from a subchronic d-limonene oral dosing study conducted by the National Cancer Institute. Food Chem Toxicol 25 (5): 355 - 8.
88. Kanerva RL, Ridder GM, Lefever FR, Alden CL,. 1987. Comparison of short-term renal effects due to oral administration of decalin or d-limonene in young adult male Fischer-344 rats. Food Chem Toxicol 25 (5): 345 - 53.
89. Kaur G, Athar M, Alam MS,. 2010. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol Carcinog 49 (3): 290 - 301.
90. Khader M, Bresgen N, Eckl PM,. 2009. In vitro toxicological properties of thymoquinone. Food Chem Toxicol 47 (1): 129 - 133.
91. Khamidulina KK, Tabolkina OS, Kasatkina TA, Doorofeeva EV,. 2005. Limonene. Toksikologicheskii Vestnik 4: 40 - 41.
92. Kim S-H, Bae HC, Park E-J, et al. 2011. Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem Biophys Res Commun 407 (1): 129 - 134.
93. Kim S-H, Park E-J, Lee CR, et al. 2012. Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells. Int J Oncol 40 (5): 1683 - 1690.
94. Kim YW, Kim MJ, Chung BY, et al. 2013. Safety evaluation and risk assessment of d-limonene. J Toxicol Environ Health B Crit Rev 16 (1): 17 - 38.
95. Kodama R, Yano T, Furukawa K, Noda K, Ide H,. 1976. Studies on the metabolism of d-limonene (p-mentha-1,8-diene). IV. Isolation and characterization of new metabolites and species differences in metabolism. Xenobiotica Fate Foreign Compd biol Syst 6 (6): 377 - 89.
96. Kubo I, Chaudhuri SK, Kubo Y, et al. 1996. Cytotoxic and antioxidative sesquiterpenoids from Heterotheca inuloides. Planta Med 62 (5): 427 - 430.
97. Kundu JK, Surh Y-J,. 2012. Emerging avenues linking inflammation and cancer. Free Radic Biol Med 52 (9): 2013 - 2037.
98. Lamberti M, Porto S, Marra M, et al. 2012. 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. J Exp Clin Cancer Res 31: 60.
99. Lapczynski A, Bhatia SP, Letizia CS, Api AM,. 2008a. Fragrance material review on nerolidol (isomer unspecified). Food Chem Toxicol 46 (11S): S247 - S250.
100. Lapczynski A, Bhatia SP, Foxenberg RJ, Letizia CS, Api AM,. 2008b. Fragrance material review on geraniol. Food Chem Toxicol 46 (11S): S160 - S170.
101. Lapczynski A, Bhatia SP, Letizia CS, Api AM,. 2008c. Fragrance material review on farnesol. Food Chem Toxicol 46 (11S): S149 - S156.
102. Legault J, Pichette A,. 2008. Potentiating effect of β -caryophyllene on anticancer activity of α-humulene, isocaryophyllene and paclitaxel. J Pharm Pharmacol 59 (12): 1643 - 1647.
103. Lei X, Lv X, Liu M, et al. 2012. Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo. Biochem Biophys Res Commun 417 (2): 864 - 868.
104. Lesgards J-F, Durand P, Lassarre M, et al. 2002. Assessment of lifestyle effects on the overall antioxidant capacity of healthy subjects. Environ Health Perspect 110: 479 - 86.
105. Lesgards J-F, Gauthier C, Iovanna J, Vidal N, Dolla A, Stocker P,. 2011. Effect of reactive oxygen and carbonyl species on crucial cellular antioxidant enzymes. Chem Biol Interact 190: 28 - 34.
106. Li G, Xie B, Li X, et al. 2012. Down-regulation of survivin and hypoxia-inducible factor-1α by β -elemene enhances the radiosensitivity of lung adenocarcinoma xenograft. Canc Biother Rad 27 (1): 56 - 64.
107. Li L-J, Zhong L-F, Jiang L-P, Geng C-Y, Zou L-J,. 2011. β -Elemene radiosensitizes lung cancer A549 cells by enhancing DNA damage and inhibiting DNA repair. Phytother Res 25 (7): 1095 - 1097.
108. Li Q, Wang G, Huang F, Banda M, Reed E,. 2010. Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol 62: 1018 - 1027.
109. Li QQ, Wang G, Zhang M, Cuff CF, Huang L, Reed E,. 2009. β -elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis. Oncol Rep 22 (1): 161 - 170.
110. Li QQ, Wang G, Liang H, et al. 2013. β -elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas. Anticancer Res 33 (4): 1421 - 1428.
111. Li X, Wang G, Zhao J, et al. 2005. Antiproliferative effect of β -elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci 62 (7-8): 894 - 904.
112. Liang D, Yang M, Guo B, Yang L, Cao J, Zhang X,. 2012. HIF-1α induced by β -elemene protects human osteosarcoma cells from undergoing apoptosis. J Cancer Res Clin Oncol 138 (11): 1865 - 1877.
113. Liang WZ, Lu CH,. 2012. Carvacrol-induced [Ca2+]i rise and apoptosis in human glioblastoma cells. Life Sci 90 (17-18): 703 - 11.
114. Liebgott T, Miollan M, Berchadsky Y, Drieu K, Culcasi M, Pietri S,. 2000. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res Cardiol 95: 368 - 377.
115. Liu J, Hu X-J, Jin B, Qu X-J, Hou K-Z, Liu Y-P,. 2012. β -Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J Pharm Pharmacol 64 (1): 146 - 153.
116. Liu J, Zhang Y, Qu J, et al. 2011. β -Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer 11: 183.
117. Loizzo MR, Tundis R, Menichini F, Saab AM, Statti GA, Menichini F,. 2007. Cytotoxic activity of essential oils from Labiatae and Lauraceae families against in vitro human tumor models. Anticancer Res 27 (5A): 3293 - 3300.
118. Loza-Tavera H,. 1999. Monoterpenes in essential oils: biosynthesis and properties. Adv Exp Med Biol 464: 49 - 62.
119. Lu J-J, Dang Y-Y, Huang M, Xu W-S, Chen X-P, Wang Y-T,. 2012. Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae - A review. J Ethnopharmacol 143 (2): 406 - 411.
120. Lu X-G, Zhan L-B, Feng B-A, Qu M-Y, Yu L-H, Xie J-H,. 2004. Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene. World J Gastroenterol 10 (14): 2140 - 2144.
121. Luo Z, Zang M, Guo W,. 2010. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 6 (3): 457 - 470.
122. Maltzman TH, Gould MN,. 1991. Mechanism of action of dietary limonene during the initiation stage of DMBA induced rat mammary carcinogenesis. Proc Am Assoc Cancer Res 31: 124.
123. Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S,. 2010. Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 86 (25-26): 936 - 941.
124. Manikandan P, Vinothini G, Vidya Priyadarsini R, Prathiba D, Nagini S,. 2011. Eugenol inhibits cell proliferation via NF-κ B suppression in a rat model of gastric carcinogenesis induced by MNNG. Invest New Drugs 29 (1): 110 - 117.
125. Manosroi J, Dhumtanom P, Manosroi A,. 2006. Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. Cancer Lett 235 (1): 114 - 120.
126. Manuele MG, Barreiro Arcos ML, Davicino R, Ferraro G, Cremaschi G, Anesini C,. 2010. Limonene exerts antiproliferative effects and increases nitric oxide levels on a lymphoma cell line by dual mechanism of the ERK pathway: relationship with oxidative stress. Cancer Invest 28 (2): 135 - 145.
127. Matsunaga T, Tsuji Y, Kaai K, et al. 2010. Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress. Cancer Chemother Pharmacol 66 (3): 517 - 526.
128. McAnally Jennifer A, Jung M, Mo H,. 2003. Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells. Cancer Lett 202 (2): 181 - 92.
129. Melnykovych G, Haug JS, Goldner CM,. 1992. Growth inhibition of leukemia cell line CEM-C1 by farnesol: effects of phosphatidylcholine and diacylglycerol. Biochem Biophys Res Commun 186 (1): 543 - 8.
130. Mezzoug N, Elhadri A, Dallouh A, et al. 2007. Investigation of the mutagenic and antimutagenic effects of Origanum compactum essential oil and some of its constituents. Mutat Res Genet Toxicol Environ Mutagen 629 (2): 100 - 110.
131. Miller Jessica A, Lang Julie E, Ley M, et al. 2013. Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer. Canc Prev Res 6 (6): 577 - 584.
132. Minet Emmanuel F, Daniela G, Meredith C, Massey Eian D,. 2012. A comparative in vitro kinetic study of [14C]-eugenol and [14C]-methyleugenol activation and detoxification in human, mouse, and rat liver and lung fractions. Xenobiotica Fate Foreign Compd Biol Syst 42 (5): 429 - 41.
133. Modzelewska A, Sur S, Kumar Srinivas K, Khan Saeed R,. 2005. Sesquiterpenes: natural products that decrease cancer growth. Curr Med Chem Anti Canc Agents 5 (5): 477 - 99.
134. N'Guessan P, Pouyet L, Gosset G, et al. 2011. Absence of tumor suppressor tumor protein 53-induced nuclear protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic fibroblasts to redox-driven apoptosis. Antioxid redox sign 15: 1639 - 53.
135. Nessa MU, Beale P, Chan C, Yu JQ, Huq F,. 2011. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Res 31 (11): 3789 - 3797.
136. Nowsheen S, Aziz K, Kryston TB, Ferguson NF, Georgakilas A,. 2012. The interplay between inflammation and oxidative stress in carcinogenesis. Curr Mol Med 12 (6): 672 - 680.
137. Ong TP, Heidor R, de Conti A, Dagli MLZ, Moreno FS,. 2006. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 27 (6): 1194 - 1203.
138. Pal D, Banerjee S, Mukherjee S, Roy A, Panda CK, Das S,. 2010. Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway. J Dermatol Sci 59 (1): 31 - 39.
139. Park K-R, Nam D, Yun H-M, et al. 2011. β -Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 312 (2): 178 - 88.
140. Peng L, Liu A, Shen Y, et al. 2013. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κ B pathway. Oncol Rep 29 (2): 571 - 578.
141. Piaru SP, Mahmud R, Abdul Majid AMS, Daoud Z, Nassar M,. 2012. Antioxidant and antiangiogenic activities of the essential oils of Myristica fragrans and Morinda citrifolia. Asian Pac J Trop Med 5 (4): 294 - 298.
142. Pietri S, Maurelli E, Drieu K, Culcasi M,. 1997. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol 29: 733 - 742.
143. Polo MP, Crespo R, de Bravo MG,. 2011. Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line. Cell Biochem Funct 29 (6): 452 - 458.
144. Rabi T, Bishayee A,. 2009. d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: generation of reactive oxygen species and induction of apoptosis. Journal of Carcinog 8: 9.
145. Randhawa MA, Alghamdi MS,. 2011. Anticancer activity of Nigella sativa (black seed) - a review. Am J Chin Med 39 (6): 1075 - 1091.
146. Rioufol G, Pietri S, Culcasi M, et al. 2003. Ginkgo biloba extract EGb 761 attenuates myocardial stunning in the pig heart. Basic Res Cardiol 98: 59 - 68.
147. Ripple GH, Gould MN, Arzoomanian RZ, et al. 2000. Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res 6 (2): 390 - 396.
148. Sakhi Amrit K, Russnes Kjell M, Thoresen M, et al. 2009. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study. BMC Cancer 9: 458.
149. Salomi MJ, Nair SC, Panikkar KR,. 1991. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer 16 (1): 67 - 72.
150. Satooka H, Kubo I,. 2012. Effects of thymol on B16-F10 melanoma cells. J Agric Food Chem 60 (10): 2746 - 2752.
151. Satou T, Takahashi M, Kasuya H, et al. 2013. Organ accumulation in mice after inhalation of single or mixed essential oil compounds. Phytother Res 27: 306 - 311.
152. Seki T, Kokuryo T, Yokoyama Y, et al. 2011. Antitumor effects of α-bisabolol against pancreatic cancer. Cancer Sci 102 (12): 2199 - 2205.
153. Sharma PR, Mondhe DM, Muthiah S, et al. 2009. Anticancer activity of an essential oil from Cymbopogon flexuosus. Chem Biol Interact 179 (2-3): 160 - 168.
154. Shin SH, Park JH, Kim GC,. 2007. The mechanism of apoptosis induced by eugenol in human osteosarcoma cells. J Korean Oral Maxillofac Surg 33: 20 - 27.
155. Slamenova D, Horvathova E, Sramkova M, Marsalkova L,. 2007. DNA-protective effects of two components of essential plant oils carvacrol and thymol on mammalian cells cultured in vitro. Neoplasma 54 (2): 108 - 12.
156. Soeur J, Marrot L, Perez P, et al. 2011. Selective cytotoxicity of Aniba rosaeodora essential oil towards epidermoid cancer cells through induction of apoptosis. Mutat Res Genet Toxicol Environ Mutagen 718 (1-2): 24 - 32.
157. Soundran V, Namagiri T, Manonayaki S, Vanithakumari G,. 1994. Hepatotoxicity of eugenol. Ancient Sci Life 13 (3-4): 213 - 7.
158. Staines AG, Sindelar P, Coughtrie MWH, Burchell B,. 2004. Farnesol is glucuronidated in human liver, kidney and intestine in vitro, and is a novel substrate for UGT2B7 and UGT1A1. Biochem J 384 (3): 637 - 645.
159. Sylvestre M, Pichette A, Lavoie S, Longtin A, Legault J,. 2007. Composition and cytotoxic activity of the leaf essential oil of Comptonia peregrina (L.) coulter. Phytother Res 21 (6): 536 - 540.
160. Thompson DC, Barhoumi R, Burghardt RC,. 1998. Comparative toxicity of eugenol and its quinone methide metabolite in cultured liver cells using kinetic fluorescence bioassays. Toxicol Appl Pharmacol 149 (1): 55 - 63.
161. Uedo N, Tatsuta M, Iishi H, et al. 1999. Inhibition by d-limonene of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Lett 137 (2): 131 - 136.
162. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J,. 2004. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266 (1&2): 37 - 56.
163. Van Duuren BL, Goldschmidt BM,. 1976. Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. J Natl Canc Ins (1940-1978) 56 (6): 1237 - 42.
164. van Lieshout EMM, Posner GH, Woodard BT, Peters WHM,. 1998. Effects of the sulforaphane analog compound 30, indole-3-carbinol, d-limonene or relafen on glutathione S-transferases and glutathione peroxidase of the rat digestive tract. Biochim Biophys Acta Gen Subj 1379 (3): 325 - 336.
165. Vander Heiden MG, Cantley LC, Thompson CB,. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Sci (New York, NY) 324 (5930): 1029 - 33.
166. Velho-Pereira R, Kumar A, Pandey Badri N, Jagtap Aarti G, Mishra Kaushala P,. 2011. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis. Cell Biol Int 35 (10): 1025 - 9.
167. Vidhya N, Devaraj SN,. 2011. Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 49 (11): 871 - 878.
168. Vieira A, Heidor R, Cardozo MT, et al. 2011. Efficacy of geraniol but not of β -ionone or their combination for the chemoprevention of rat colon carcinogenesis. Braz J Med Biol Res 44 (6): 538 - 545.
169. Vigushin DM, Poon GK, Boddy A, et al. 1998. Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Chemother Pharmacol 42 (2): 111 - 117.
170. Vinothkumar V, Manoharan S,. 2011. Chemopreventive efficacy of geraniol against 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Redox Rep 16 (3): 91 - 100.
171. Warburg O,. 1956. On the origin of cancer cells. Science 123 (3191): 309 - 14.
172. Warburg O,. 1930. Ueber den stoffwechsel der tumoren. Constable: London.
173. Wattenberg LW, Coccia JB,. 1991. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12 (1): 115 - 17.
174. Webb DR, Kanerva RL, Hysell DK, Alden CL, Lehman-McKeeman LD,. 1990. Assessment of the subchronic oral toxicity of d-limonene in dogs. Food Chem Toxicol 28 (10): 669 - 75.
175. Whysner J, Williams GM,. 1996. d-Limonene mechanistic data and risk assessment: absolute species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71 (1/2): 127 - 136.
176. Wiseman DA, Werner SR, Crowell PL,. 2007. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21Cip1 and p27Kip1 in human pancreatic adenocarcinoma cells. J Pharmacol Exp Therapeut 320 (3): 1163 - 1170.
177. Xu H-B, Li L, Fu J, Mao X-P, Xu L-Z,. 2012. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β -elemene. Pharmacology 89 (5-6): 303 - 312.
178. Yoo C-B, Han K-T, Cho K-S, et al. 2005. Eugenol isolated from the essential oil of Eugenia caryoplyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett 225 (1): 41 - 52.
179. Yu SG, Hildebrandt LA, Elson CE,. 1995. Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice. J Nutr 125 (11): 2763 - 7.
180. Zhao J, Li QQ, Zou B, et al. 2007. In vitro combination characterization of the new anticancer plant drug ss-elemene with taxanes against human lung carcinoma. Int J Oncol 31 (2): 241 - 252.
181. Zhao Y-S, Zhu T-Z, Chen Y-W, et al. 2012. B-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. Neuro Oncol 107 (2): 307 - 14.
182. Zhong Z, Chen X, Tan W, et al. 2011. Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis. Eur J Pharmacol 667 (1-3): 50 - 55.
183. Zhu T, Zhao Y, Zhang J, et al. 2011. β -elemene inhibits proliferation of human glioblastoma cells and causes cell-cycleG0/G1 arrest via mutually compensatory activation of MKK3 and MKK6. Int J Oncol 38 (2): 419 - 426.
184. Zu Y, Yu H, Liang L, et al. 2010. Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. Molecules 15: 3200 - 3210.